Table 1.
Patient | Age/Race/Sex | Stage | On- study TBSA |
BSA irradiated |
Type of lesions |
Cycle | Energy | Dose per fraction |
No. of fractions |
---|---|---|---|---|---|---|---|---|---|
1 | 41/W/M | IIB | 16% | 2.5% | plaques | 6-7 | 9 MeV | 180 cGy | 20 |
2.0% | plaques | 43-44 | 6 MeV | 180 cGy | 20 | ||||
| |||||||||
2 | 41/W/F | IVA2 | 91.5% | 8.6% | papules | 10 | 6 MeV | 600 cGy | 4 |
9.7% | papules | 11 | 6 MeV | 400 cGy | 6 | ||||
10.7% | plaques | 12 | 6 MeV | 400 cGy | 8 | ||||
| |||||||||
3 | 61/W/F | IIB | 0.8%a | 0.3% | tumors | 3 | 6 MeV | 400 cGy | 12 |
0.1 | tumors | 4 | 6 MeV | 400 cGy | 4 | ||||
0.1 | tumors | 6 | 6 MeV | 400 cGy | 6 | ||||
0.01 | tumor | 12 | 6 MeV | 400 cGy | 2 | ||||
| |||||||||
4 | 34/AA/F | IVA2 | 82% | 6% | plaques | 10 - 11 |
6 MeV | 180 cGy | 10 |
| |||||||||
5 | 42/W/M | IIB | 36.5%b | 2.9% | tumors | 7 | 6 MeV | 200 cGy | 5 |
2.0% | plaques | 10 | 6 MeV | 200 cGy | 5 |
TBSA, Total Body Surface Area for patches and plaques only; BSA, Body Surface Area;
All CTCL lesions were tumors.
Patient had tumors occupying additional 10% of TBSA